Six-year-olds: Novo’s new frontier for weight-loss drugs
Headline via Financial Times · first report 16 Nov, 20:30 IST, latest 16 Nov, 21:30 IST
What we know
2 independent news organisations have reported this story. The first report we saw came from Financial Times at 16 Nov, 20:30 IST; the latest is from Medical Xpress at 16 Nov, 21:30 IST. Rational Times has not independently confirmed the details: read each report through the links below.
What the reports sayEach newsroom’s own summary of its report, from its feed
Wegovy helped almost 8 in 10 children as young as 6 lose more than 10% of their BMI in trial
Medicaid prescriptions for weight loss–approved GLP-1 medications fell sharply after four states ended coverage of the drugs, according to a new study led by researchers at the University of Pittsburgh. The findings, published in JAMA, demonstrate how state…
Quoted from the newsrooms’ own feeds, with their names and links. Rational Times has not independently confirmed the details.
The reports2 reports
- Financial Times Six-year-olds: Novo’s new frontier for weight-loss drugs
- Medical Xpress Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use
Headlines belong to the news organisations named; each links to their own report. We group reports automatically by their key words, so now and then two different stories can be grouped together, or one story split in two. Tell us about a mistake
Rational






